Oscar Health (NYSE:OSCR) PT Raised to $21.00 at The Goldman Sachs Group
The Cerbat Gem -

Oscar Health (NYSE:OSCR – Get Free Report) had its price target upped by equities research analysts at The Goldman Sachs Group from $16.00 to $21.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage presently has a “neutral” rating on the stock. The Goldman Sachs Group’s target price suggests a potential […]

In related news